Navigation Links
ORTHOCON® Announces U.S. Market Launch of HEMASORB®
Date:2/17/2011

IRVINGTON, N.Y., Feb. 17, 2011 /PRNewswire/ -- ORTHOCON, Inc., a developer of implantable products designed to stop the bleeding from and to deliver drugs to bone, today announced the U.S. launch of its first commercial product, the HEMASORB Absorbable Bone Hemostat Matrix.

The HEMASORB Absorbable Bone Hemostat Matrix is a ready to use, biocompatible, water resistant, and absorbable putty that is designed to rapidly stop bleeding when applied to damaged or cut bone. HEMASORB was cleared for market introduction by the U.S. Food and Drug Administration (FDA) via the 510(k) premarket notification process. In 2010, ORTHOCON conducted a limited market introduction of this product under its development name, ORTHOstat.

"We believe that HEMASORB is an innovative product that addresses a substantial market opportunity and has the potential to become a standard of care," said John J. Pacifico, President and Chief Executive Officer of ORTHOCON. "It is easy to use; it satisfies unmet needs and it is cost-effective."

Bleeding from cut bone is a common occurrence in many operative procedures. Excessive bleeding from bone during surgery may impair the surgeon's view of the operative field, may result in the need for blood transfusions and may be associated with post-operative complications. ORTHOCON estimates that over 3.5 million patients undergoing surgeries in the U.S. and Europe each year could benefit from the intra-operative use of HEMASORB.

"HEMASORB is the first commercial product that employs our proprietary Syntinate Technology Platform," commented Richard L. Kronenthal, Ph.D., ORTHOCON's Scientific Founder. "We are currently developing a pipeline of follow-on products that will complement Syntinate's utility as a bone hemostat by exploiting its unique potential to deliver drugs directly to bone."

The Syntinate Technology Platform incorporates biocompatible and absorbable soli
'/>"/>

SOURCE ORTHOCON, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Orexigen® Therapeutics, Inc. Announces Upcoming Departure of Chief Financial Officer
2. In Celebration of the 31st Annual Dialysis Conference, NxStage® Announces Over 5,000 Patients Using the System One™ for Home Hemodialysis
3. BioDelivery Sciences Announces BEMA Buprenorphine Phase 3 Chronic Pain Study More Than 50% Recruited and on Schedule
4. Alere Inc. Announces Fourth Quarter 2010 Results
5. Kips Bay Medical Announces Closing of its $16.5 Million Initial Public Offering of Common Stock
6. 6th Annual New York Stem Cell Summit Announces Spinal Cord Injury Panel Participants
7. Onyx Pharmaceuticals Announces Fourth Quarter and Full Year 2010 Financial Results Teleconference and Webcast
8. Warner Chilcott Announces Earnings Release Date and Conference Call for Fourth Quarter and Full Year 2010 Financial Results
9. Gen-Probe Announces $150 Million Stock Repurchase Plan
10. Genus Oncology, LLC Announces Initiation of Phase I Trial of GO-203-2c in Patients With Solid Tumors
11. Endologix Announces Presentation of Favorable Initial PEVAR Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... KENNEBUNK, Maine , Dec. 22, 2014 /PRNewswire/ ... an analysis brief providing a summary of the ... health plan enrollment trends.  According ... Secretary for Planning and Evaluation, Department of Health ... people were enrolled in individual medical plans through ...
(Date:12/22/2014)... , Dec. 22, 2014  Relmada Therapeutics, ... therapies for the treatment of chronic pain, announced ... been dosed in a pharmacokinetic and pharmacodynamic study ... for neuropathic pain. Racemic methadone is ... various pain states and substitution therapy in opioid ...
(Date:12/19/2014)... 19, 2014 TODAY, AEGATE, the ... World announced the appointment of Peter Fox ... Chief Channels and Partner Officer. Peter has ... to its acquisition by Oracle in 2011. ... Geneva and subsequently Convergys, a world ...
Breaking Medicine Technology:Insights into the Marketplace and Individual Market Growth 2Relmada Therapeutics Doses First Cohort of Subjects in Human Clinical Trial of d-Methadone 2Relmada Therapeutics Doses First Cohort of Subjects in Human Clinical Trial of d-Methadone 3Aegate Appoints new CTO and Chief Channels & Partner Officer 2Aegate Appoints new CTO and Chief Channels & Partner Officer 3Aegate Appoints new CTO and Chief Channels & Partner Officer 4
... , PHILADELPHIA, Dec. ... SHPGY ), the global specialty biopharmaceutical company, announced the launch ... Support Twitter(TM) page ( http://twitter.com/adhdsupport ), derived from the Shire ... social networking service Twitter, estimated to reach approximately six million ...
... Dec. 21 Soligenix, Inc. (OTC Bulletin Board: SNGX) ... Inc., a late-stage biotechnology company, announced today that it ... a time-release formulation of oral beclomethasone 17,21-dipropionate (oral BDP), ... will be supported in large part by a two-year ...
Cached Medicine Technology:Shire Expands its Award-Winning ADHD Support Resource, ADHDSupport.com, by Launching an ADHD Twitter(TM) Page 2Shire Expands its Award-Winning ADHD Support Resource, ADHDSupport.com, by Launching an ADHD Twitter(TM) Page 3Shire Expands its Award-Winning ADHD Support Resource, ADHDSupport.com, by Launching an ADHD Twitter(TM) Page 4Shire Expands its Award-Winning ADHD Support Resource, ADHDSupport.com, by Launching an ADHD Twitter(TM) Page 5Soligenix Announces Initiation of a Phase 1/2 Clinical Trial of SGX201 for the Prevention of Acute Radiation Enteritis 2Soligenix Announces Initiation of a Phase 1/2 Clinical Trial of SGX201 for the Prevention of Acute Radiation Enteritis 3Soligenix Announces Initiation of a Phase 1/2 Clinical Trial of SGX201 for the Prevention of Acute Radiation Enteritis 4Soligenix Announces Initiation of a Phase 1/2 Clinical Trial of SGX201 for the Prevention of Acute Radiation Enteritis 5Soligenix Announces Initiation of a Phase 1/2 Clinical Trial of SGX201 for the Prevention of Acute Radiation Enteritis 6
(Date:12/22/2014)... Gables, FL (PRWEB) December 22, 2014 Coral ... lice removal service , Lice Troopers, with its new clinic ... in southern Florida, takes the hassle out of dealing with ... services in one of their two salon clinic locations in ... or other location. , The decision to expand developed naturally ...
(Date:12/22/2014)... International efforts to combat ... are receiving further support from recent initiatives ... (NGOs) and other charitable organizations. While research ... responders, patients and others can immediately benefit ... CmTP MediDefense system , which includes ...
(Date:12/22/2014)... Super Saturday, the last Saturday before ... the busiest day in the 2014 holiday shopping season. ... had a steady pre-Christmas stream of customers, ready to ... , “I definitely intend to take advantage…of the recreational ... who was enjoying The Grass Station’s holiday sale on ...
(Date:12/22/2014)... (PRWEB) December 22, 2014 The MedTech industry ... Inc, a wholly owned subsidiary of PartnerTech AB of Sweden, ... having recently achieved additional ISO Certification. , All signs point ... employment and the likelihood of a repeal of the excise ... . The industry is anticipating annual growth of 9.3% and ...
(Date:12/22/2014)... Luxury Linen purveyor Peacock Alley once again ... provide logistics and support for one of Dallas’ largest holiday ... history of giving back to the community in which it ... Drive were Whataburger® and 99.5 The Wolf. , There is ... gifts to children who would otherwise not receive any is ...
Breaking Medicine News(10 mins):Health News:Professional In-Home All-Natural Lice Removal Service Expands to Coral Gables and surrounding areas. 2Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 2Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 3Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 4Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 5Health News:Customers at Colorado’s Grass Station Say They’re Enjoying the Experience of Legally Purchasing Marijuana this Year to Give as Christmas Presents to Friends and Family 2Health News:PartnerTech Inc. Poised for Growth in MedTech 2Health News:Peacock Alley and Community Partners of Dallas Fulfill an Estimated 12,000 Holiday Wishes for Deserving Children 2
... Medical Innovations, Inc. (NYSE: IMA ), a ... their health at home through the merger of rapid ... attend the Deutsche Bank 34th Annual Health Care Conference ... the InterContinental Boston. Ron Zwanziger, Chief Executive Officer, ...
... anti-inflammatory components in ginseng , , FRIDAY, May 15 ... medicine for centuries, and now its reputation for ... found that the herb, which is used in ... , Researchers from the University of Hong Kong ...
... accelerate expansion of industry-leading $3.50 prescription drug ... privately held Delaware corporation, and Clacendix, Inc. ... completion of their business combination pursuant to ... will assume and execute the HealthWarehouse.com business ...
... Company Signs Agreement with Given Imaging Ltd. to ... 15 Alpine Biomed Corporation, a global leader ... has signed an agreement with Given Imaging Ltd. ... company,s GastroTrac(R) gastroenterology software suite will interface with ...
... intervene and keep kids safe, study finds , , FRIDAY, ... family togetherness can be a tool to prevent teens ... insight into the role played by fathers when they ... previous evidence that suggested parents detach when they realize ...
... The Scleroderma Foundation applauds Rep. Lois Capps ... H.R. 2408, the " Scleroderma Research and Awareness ... This bipartisan legislation gives hope to the estimated ... devastating disease.Scleroderma is a chronic and disabling connective ...
Cached Medicine News:Health News:Inverness Medical Innovations to Present at the Deutsche Bank 34th Annual Health Care Conference on May 19, 2009 2Health News:New Discovery Shows Ancient Herb Fights Inflammation 2Health News:HealthWarehouse.com, Inc. Announces Completion of Business Combination With Clacendix, Inc. 2Health News:HealthWarehouse.com, Inc. Announces Completion of Business Combination With Clacendix, Inc. 3Health News:Alpine Biomed Corporation to Integrate Bravo pH Monitoring With GastroTrac Software to Enhance Gastrodiagnostic Testing Capabilities 2Health News:Fathers' Concern Rises When Teens Start Having Sex 2Health News:The Scleroderma Foundation Applauds Introduction of First Bill In Congress Promoting Research and Awareness of Scleroderma 2
... Preserve your data for future generations. Most ... the solid backing plate of our gel dryer, ... a frame over them to hold the cellophane ... a frame with an open area somewhat larger ...
... Slim Slab Gel Dryer accommodates large sequencing gels or ... TEFLON coated platen for long lasting durability and corrosion ... , Quick Drying Rate - large ... , Digital display of temperature and time ...
Inquire...
... gel-drying system, Hoefers Easy Breeze can dry as many ... 24 Mini-Gels (8 x 10 cm) at a time. ... air drying oven, a specially designed loading platform, and ... trap, no awkward connections., The Gel Frame is largely ...
Medicine Products: